Prestige Consumer Healthcare (PBH)
NYSEHealth CareMedical - PharmaceuticalsSnapshot 2026-09-04
$52.26-0.57%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - PharmaceuticalsSnapshot 2026-09-04
QuarterlyIQ Insights · PBH
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(0.5) + peer(0.2*-2.5) + term(2.0) → 1.66% (capped ±15.0)
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition. On August 6, 2026, Prestige Consumer Healthcare Inc. (the “Company”) announced financial results for the fiscal quarter ended June 30, 2026. A copy of the press release announcing the Company's earnings results for the fiscal quarter ended June 30, 2026 is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operations and Financial Condition. On May 13, 2026, the Company announced financial results for the fiscal quarter and year ended March 31, 2026. A copy of the press release announcing the Company's earnings results for the fiscal quarter and year ended March 31, 2026 is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.
Results of Operations and Financial Condition. On February 5, 2026, Prestige Consumer Healthcare Inc. (the “Company”) announced financial results for the fiscal quarter and nine months ended December 31, 2025. A copy of the press release announcing the Company's earnings results for the fiscal quarter and nine months ended December 31, 2025 is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Results of Operations and Financial Condition. On November 6, 2025, Prestige Consumer Healthcare Inc. (the “Company”) announced financial results for the fiscal quarter and six months ended September 30, 2025. A copy of the press release announcing the Company's earnings results for the fiscal quarter and six months ended September 30, 2025 is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Results of Operations and Financial Condition. On August 7, 2025, the Company announced financial results for the fiscal quarter ended June 30, 2025. A copy of the press release announcing the Company's earnings results for the fiscal quarter ended June 30, 2025 is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Results of Operations and Financial Condition. On May 8, 2025, Prestige Consumer Healthcare Inc. (the “Company”) announced financial results for the fiscal quarter and year ended March 31, 2025. A copy of the press release announcing the Company's earnings results for the fiscal quarter and year ended March 31, 2025 is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.
Results of Operations and Financial Condition. On February 6, 2025, Prestige Consumer Healthcare Inc. (the “Company”) announced financial results for the fiscal quarter and nine months ended December 31, 2024. A copy of the press release announcing the Company's earnings results for the fiscal quarter and nine months ended December 31, 2024 is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Results of Operations and Financial Condition. On November 7, 2024, Prestige Consumer Healthcare Inc. (the “Company”) announced financial results for the fiscal quarter and six months ended September 30, 2024. A copy of the press release announcing the Company's earnings results for the fiscal quarter and six months ended September 30, 2024 is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Results of Operations and Financial Condition. On August 8, 2024, Prestige Consumer Healthcare Inc. (the “Company”) announced financial results for the fiscal quarter ended June 30, 2024. A copy of the press release announcing the Company's earnings results for the fiscal quarter ended June 30, 2024 is attached hereto as Exhibit 99.1 and incorporated herein by reference.
above is incorporated by reference as if fully set forth herein. On May 14, 2024, representatives of the Company began making presentations to investors regarding the Company's financial results for the quarter and year ended March 31, 2024 using slides containing the information attached to this Current Report on Form 8-K as Exhibit 99.2 (the “Investor Presentation”). The Company expects to use the Investor Presentation, in whole or in part, and possibly with modifications, in connection wit…